Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.53 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21128675 | 0.86 | LMNA (0.51) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL22017568 | 0.86 | LMNA (0.51) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL17792625 | 0.84 | PTGS2 (0.48) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL17789149 | 0.82 | PTGS2 (0.46) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL11344390 | 0.77 | PTGS2 (0.71) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL30593451 | 0.77 | PTGS2 (0.71) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL11520899 | 0.76 | LMNA (0.58) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL9797153 | 0.75 | MEN1 (0.57) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL29481378 | 0.73 | CHRM1 (0.54) | LMNAPTGS2MEN1CYP3A4KMT2A | |
| SCHEMBL10504416 | 0.73 | LMNA (0.54) | LMNAPTGS2MEN1CYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3023108-B1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU KOGYO CO LTD (JP) | 2021-04-07 | — | — | EP | disclosed |
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | SEIKAGAKU CORPORATION (JP) | 2016-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160151506-A1 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | CSGALNACT1, CD44, GUSB | LMNA 2311/4885PTGS2 366/4885MEN1 3596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.